Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: First in Human Study of TUB-030 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

First-in-human study of TUB-030 is underway in patients with advanced solid tumors, including head and neck squamous cell carcinoma, small cell lung cancer, non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TUB-030

Snippet

Sponsor: Tubulis GmbH | Conditions: Advanced Solid Tumors, HNSCC | Phase 1, Phase 2 | Status: RECRUITING